Posted November 05, 2018 09:21:24 When a woman was rushed to the intensive care unit at the northside Hospital for Sick Children (SickKids) with a suspected case of Ebola, it was a frightening experience.
But it was not a surprise.
The mother-of-four has been on a number of medications that are often prescribed to people who have recently had a medical emergency.
So, when she was told she was being given the drug ZMapp, the mother of three knew exactly what to expect.
She was told it was for a rare disease that affects a specific strain of Ebola.
Her husband, John, is also a health care worker.
John says his daughter was told they were going to take her on ZMamprosy to “get her to a safe place”.
He says the drug was prescribed for a strain of the virus that is known to be resistant to other drugs.
“They just told me, ‘Go to bed and be safe, we don’t want you to come home sick’,” he says.
“But we were really, really worried.”
ZMoprosy is a drug that has been approved for use in the US by the US Food and Drug Administration.
But the drug can cause severe side effects, including nausea and vomiting.
The woman was given the medication because she had a “relatively high risk of having a potentially fatal Ebola infection,” according to the department of health.
But she was not being given ZMprosy.
ZMeprosy has been used to treat patients with Ebola since the outbreak began in West Africa, and has been a success.
It has been shown to treat more severe Ebola infections than other drugs on the market.
But some of the drugs are being phased out as people are increasingly desperate to avoid having a deadly infection.
“It’s not a drug you can just drop on anybody, especially if you have an ongoing illness,” says Dr. Chris Mould, a health policy expert at the University of Melbourne.
“If you’ve had a fever, a cough, an attack, it’s a pretty good drug to try and treat a fever or a cough.”
But the man who was given Zmprosy was not getting treatment from his doctors.
He had not tested positive for Ebola and did not have any symptoms, according to Mould.
When his symptoms worsened, he was taken to the hospital.
“He was just in shock, just really distressed, and it was just too much,” Mould says.
The man died two days later.
“What we need to remember is that if we want to treat this outbreak and stop it, we need a lot more of the same kind of medicine, that’s for sure,” he says, adding that the “most effective and cost-effective” way to treat Ebola is to get people tested.
“We need to get more people tested, we have to do more testing, and we need better access to that kind of medication,” he adds.
“This isn’t just an isolated incident, this is an epidemic that is not going away.
We need to act, and act fast.”
The man’s case is not the only one that has highlighted the need for increased testing, especially in hospitals.
The health department has released guidelines for doctors to ask about patients’ symptoms and other signs of Ebola infection.
But Mould said the new guidelines were only starting to make a difference.
“People are going to continue to die, but it’s important to be prepared, especially for the sickest and most vulnerable,” he said.
“A doctor should be able to prescribe ZMiprosy or ZMuprosy, but we need more doctors to know what the drug is really for.”